Scancell Holdings (SCLP)


Latest News

Scancell notes continued progress on SCIB1

Scancell Holdings has provided an update on SCIB1, the lead programme from the company's ImmunoBody platform, and...

Continued Progress on SCIB1

RNS Number: 5950K Scancell Holdings Plc 11 July 2017 11 July 2017 Scancell Holdings Plc ("Scancell" or the "Company") Continued progress on SCIB1 - eight patients reach 5 year survival milestone US IND on schedule for submission in 3Q17; New batch of SCIB1 for planned US CI combination study successfully manufactured Most resected Stage III and IV melanom...

Scancell notes ImmunoBody patent granted in Europe

Scancell Holdings said a patent for its DNA ImmunoBody technology has now been granted in Europe. The European pate...

DNA ImmunoBody Patent Granted in Europe

RNS Number: 0805J Scancell Holdings Plc 26 June 2017 26 June 2017 Scancell Holdings Plc ("Scancell" or the "Company") DNA ImmunoBody Patent Granted in Europe Scancell Holdings plc, ('Scancell' or the 'Company') the developer of novel immunotherapies for the treatment of cancer, is pleased to announce that a patent for its DNA ImmunoBody technology has...

All News

11-07-17Scancell notes continued progress on SCIB1StockMarketWire
11-07-17Continued Progress on SCIB1RNS
26-06-17Scancell notes ImmunoBody patent granted in EuropeStockMarketWire
26-06-17DNA ImmunoBody Patent Granted in EuropeRNS
22-05-17Holding(s) in CompanyRNS
19-05-17Holding(s) in CompanyRNS
19-05-17Holding(s) in CompanyRNS
11-05-17Results of PlacingRNS
11-05-17Scancell proposes raising up to £5.0mStockMarketWire
11-05-17Proposed Placing to Raise up to ?5.0 millionRNS
13-04-17Scancell changes registered officeStockMarketWire
13-04-17Change of Registered OfficeRNS
20-03-17Immuno-Oncology Summit Europe 2017RNS
13-03-17Scancell eyes fundraising for Phase II SCIB1 trialStockMarketWire
13-03-17Hardman Research: SCIB development updateRNS
01-03-17Holding(s) in CompanyRNS
31-01-17Scancell widens H1 pretax lossStockMarketWire
31-01-17Interim ResultsRNS
30-01-17Scancell in partnership to advance lung cancer clinical trialsStockMarketWire
30-01-17Partnership to Advance Lung Cancer Clinical TrialsRNS
03-01-17Research Update - AmendmentRNS
03-01-17Scancell Holdings issues research updateStockMarketWire
03-01-17Research UpdateRNS
14-11-16World Immunotherapy Congress and Biotech and MoneyRNS
18-10-16Results of AGMRNS
10-10-16Preparing SCIB2 for clinical study in lung cancerRNS
26-09-16Hardman Report: New frontiers in T-cell activationRNS
23-09-16Notice of AGM - AmendmentRNS
23-09-16Scancell Holdings schedules AGMStockMarketWire
23-09-16Notice of AGMRNS
16-09-16Scancell widens H1 pretax loss StockMarketWire
16-09-16Final ResultsRNS
07-09-16NewsMakers in the Biotech Industry ConferenceRNS
22-08-16Appointment of Non-Executive DirectorRNS
21-07-16Eurogentec manufacturing agreementRNS
20-07-16Scancell extends Ichor commercial optionStockMarketWire
20-07-16Extension to Ichor Commercial OptionRNS
13-07-16Peer-reviewed publication on Moditope? platformRNS
06-07-16Scancell notes SCIB1 compelling survival data StockMarketWire
06-07-16SCIB1 compelling survival data in melanomaRNS

RSS feeds

  • Editorial news feed for LSE:SCLP Editorial
  • Regulatory news feed for LSE:SCLP Regulatory